Parkway Life REIT

C2PU.SI : Singapore Exchange

3.780

0.00%

Share Price in SGD. As of 30 Oct 17:04:35 SGT

All

Chart

Key stats

Parkway Life REIT’s share price has increased by 13.2% over the past 1 year. It has underperformed the Singapore stock market during this period.

Share Price Performance
  • 52 Week Range

    SGD 3.330 - 4.330

  • Price vs 5-year high/low

    Not close

  • C2PU.SI Market
    1 Month -10.0% -0.7%
    YTD 2.4% 10.2%
    1 Year 13.2% 16.1%
    5 Year 16.7% 10.9%
Valuation
Financial
Dividend

Recently happened to Parkway Life REIT

Parkway Life Reit’s five-year journey to the West

24 Oct 2024 • News

View more
Parkway Life REIT announced dividend per share (DPS) of S$0.05

24 Oct 2024 • Dividend

View upcoming dividend payment
Parkway Life REIT has announced 1H 2024 Results Summary.

Earnings

View earnings highlights
Beansprout Analysis

Beansprout's Checklist

Fundamental
  • Occupancy Rate of 100.0% is inline with sector average of 100.0%

  • Net property income yield of 6.24% is higher than its dividend yield of 4%

Financial
  • Gearing Ratio of 0.36x is lower than sector average of 0.38x

  • Interest Coverage Ratio of 11.1x is above 2.5x

  • Net Book Value of $2.34 is higher than its net book value of $2.33 in the previous year

Valuation
  • Dividend Yield of 4% is lower than sector average of 5.8%

  • Distribution per unit growth is 2.71%

  • Price to Book of 1.61x is higher than sector average of 1.27x


Get your free exclusive guide on using our checklist to analyse your favourite REITs!

Compare REITs

Have another REIT in mind?
Select a REIT to compare with Parkway Life REIT

Revenue Breakdown by Asset

Revenue Breakdown by Geography

Market Analysis

Consensus Share Price Target

Parkway Life REIT’s price target is $4.42, according to consensus estimates as of 30 Oct 2024. Parkway Life REIT’s with a price target of $4.42 and current price of $3.78, has an upside potential of 16.9%.

Price Target: $4.420

Sell
Underperform
Neutral
Outperform
Buy

Source: SGX as of 30 Oct 2024

Analyst Ratings

  • CGS-CIMB

    05 Feb 2024

    Add

    4.500

  • OCBC Investment

    02 May 2024

    Buy

    4.290

    (prev 4.270)

  • UOB Kay Hian

    15 May 2024

    Buy

    5.070

Analyst Reports

Valuation
Earnings
Financials
News
Profile

Company Description

Parkway Life REIT is established by Parkway Holdings Limited to invest primarily in income-producing real estate and/or real estate-related assets in the Asia-Pacific region (including Singapore) that are used primarily for healthcare and/or healthcare-related purposes (including but not limited to, hospitals, healthcare facilities and real estate and/or real estate assets used in connection with healthcare research, education, and the manufacture or storage of drugs, medicine and other healthcare goods and devices), whether wholly or partially owned, and whether directly or indirectly held through the ownership of special purpose vehicles whose primary purpose is to own such real estate. The Manager of Parkway Life REIT, PHR Management Pte Ltd was incorporated in Singapore on 19 April 2007 and changed its name to Parkway Trust Management Pte Ltd. The Manager subsequently changed its name to Parkway Trust Management Limited on 12 July 2007. The Manager’s key financial objective is to provide Unitholders with attractive total returns by, among other things: a) acquiring healthcare dedicated investment properties that meet the Manager’s investment criteria; b) actively managing Parkway Life REIT’s property portfolio to enhance the returns from the property portfolio; and c) employing appropriate capital financing and hedging strategies to manage fluctuation risks in interest rates and foreign exchange risks. Parkway Life REIT will initially invest in and own the following properties, all of which are located in Singapore: The Mount Elizabeth Hospital Property; The Gleneagles Hospital Property; and The East Shore Hospital Property